Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021

  • ID: 3734880
  • Report
  • Region: Global, America, Europe, North America, United States
  • 149 Pages
  • Markets and Markets
1 of 5
The Varicose Vein Treatment Market in North America and Europe Expected to Reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% Between 2016 and 2021

FEATURED COMPANIES

  • Biolitec Ag (Austria)
  • Lumenis Ltd. (Israel)
  • Medtronic, PLC (U.S.)
  • MORE
The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 million by 2021 from USD 207.9 million in 2016, at a CAGR of 6.9% between 2016 and 2021. North America is expected to hold the largest share of the varicose vein treatment market in 2016. The varicose vein treatment market is broadly segmented into mode of treatment and products. By products, the varicose vein treatment market is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. In 2016, the radiofrequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment.

Geographically, the report covers two major geographies, namely, North America and Europe. In this report, the North American varicose vein treatment market is further segmented into the U.S. and Canada, while the European varicose vein treatment market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the varicose vein treatment market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.

Market growth is majorly driven by the shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, huge burden of varicose vein cases in North America and Europe, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.

As of 2015, the varicose vein treatment market was dominated by Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); and biolitec AG (Austria) which together held a share of over 85% of the varicose vein treatment market. New product launches, strategic acquisitions, and agreements are the major strategies adopted by most market players to achieve growth in the varicose vein treatment market.

Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis —market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the varicose vein treatment market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on varicose vein treatment products offered by the top 5 players in the varicose vein treatment market. The report analyzes the varicose vein treatment market by mode of treatment and products

- Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, product enhancements, and new product launches in the varicose vein treatment market

- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various varicose vein treatment devices across North America and Europe

- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the varicose vein treatment market
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Biolitec Ag (Austria)
  • Lumenis Ltd. (Israel)
  • Medtronic, PLC (U.S.)
  • MORE
1. Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study

2.Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation Models
2.3 Market Size Estimation Steps
2.4 Market Breakdown and Data Triangulation
2.5 Research Assumptions

3. Executive Summary
3.1 Introduction
3.2 Snapshot of Market in North America and Europe

4. Market Dynamics
4.1 Market Segmentation
4.2 Overview
4.3 Key Market Drivers
4.4 Key Market Restraints
4.5 Key Market Opportunities
4.6 Key Market Challenges

5. Varicose Vein Treatment Market in North America and Europe, By Treatment Mode
5.1 Introduction
5.2 Endovenous Ablation
5.3 Injection Sclerotherapy
5.4 Surgical Ligation/Stripping

6. Varicose Vein Treatment Market in North America and Europe, By Product
6.1 Introduction
6.2 Ablation Devices
6.2.1 Radiofrequency Ablation Devices
6.2.2 Laser Ablation Devices
6.3 Venous Closure Products
6.4 Surgical Products

7. Varicose Vein Treatment Market, By Region
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 France
7.3.3 U.K.
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe (RoE)

8. Competitive Landscape
8.1 Introduction
8.2 Market Share Analysis
8.3 Competitive Scenario
8.4 Recent Developments
8.4.1 New Product Launches
8.4.2 Acquisitions
8.4.3 Agreements
8.4.4 Other Developments

9. Company Profiles
9.1 Introduction
9.1.1 Geographic Benchmarking
9.2 Angiodynamics, Inc. (U.S.)
9.3 Medtronic, PLC (U.S.)
9.4 Biolitec Ag (Austria)
9.5 Syneron Medical Ltd. (Israel)
9.6 Lumenis Ltd. (Israel)

10. Appendix
10.1 Discussion Guide
10.2 Introducing RT: Real-Time Market Intelligence

List of Tables

Table 1 Prevalence of Varicose Veins in the European Region
Table 2 Prevalence of Primary Varicose Veins in European Region (2013) (Thousand)
Table 3 Reimbursement Scenario for Varicose Vein Treatments in Europe, By Country
Table 4 Market Size, By Treatment Mode, 2014-2021 (USD Million)
Table 5 Varicose Vein Treatment Modes Market Size, By Region, 2014-2021 (USD Million)
Table 6 Varicose Vein Treatment Modes Market Size (USD Million) and Market Share (%), By Country, 2016
Table 7 North America: Varicose Vein Treatment Modes Market Size, By Country, 2014-2021 (USD Million)
Table 8 Europe: Varicose Vein Treatment Modes Market Size, By Country, 2014-2021 (USD Million)
Table 9 Endovenous Ablation Market Size, By Region, 2014-2021 (USD Million)
Table 10 North America: Endovenous Ablation Market Size, By Country, 2014-2021 (USD Million)
Table 11 Europe: Endovenous Ablation Market Size, By Country, 2014-2021 (USD Million)
Table 12 Injection Sclerotherapy Market Size, By Region, 2014-2021 (USD Million)
Table 13 North America: Injection Sclerotherapy Market Size, By Country, 2014-2021 (USD Million)
Table 14 Europe: Injection Sclerotherapy Market Size, By Country, 2014-2021 (USD Million)
Table 15 Surgical Ligation/Stripping Market Size, By Region, 2014-2021 (USD Million)
Table 16 North America: Surgical Ligation/Stripping Market Size, By Country, 2014-2021 (USD Million)
Table 17 Europe: Surgical Ligation/Stripping Market Size, By Country, 2014-2021 (USD Million)
Table 18 Market Size, By Product, 2014-2021 (USD Million)
Table 19 Varicose Vein Treatment Product Market Size, By Region, 2014-2021 (USD Million)
Table 20 North America: Varicose Vein Treatment Product Market Size, By Country, 2014-2021 (USD Million)
Table 21 Europe: Varicose Vein Treatment Product Market Size, By Country, 2014-2021 (USD Million)
Table 22 Varicose Vein Treatment Ablation Devices Market Size, By Type, 2014-2021 (USD Million)
Table 23 Ablation Devices Market Size, By Region, 2014-2021 (USD Million)
Table 24 North America: Ablation Devices Market Size, By Country, 2014-2021 (USD Million)
Table 25 Europe: Ablation Devices Market Size, By Country, 2014-2021 (USD Million)
Table 26 Radiofrequency Ablation Devices Market Size, By Region, 2014-2021 (USD Million)
Table 27 North America: Radiofrequency Ablation Devices Market Size, By Country 2014-2021 (USD Million)
Table 28 Laser Ablation Devices Market Size, By Region, 2014-2021 (USD Million)
Table 29 North American Venous Closure Products Market Size, By Country, 2014-2021 (USD Million)
Table 30 North America: Laser Ablation Devices Market Size, By Country 2014-2021 (USD Million)
Table 31 Europe: Laser Ablation Devices Market Size, By Country, 2014-2021 (USD Million)
Table 32 Venous Closure Products Market Size, By Region, 2014-2021 (USD Million)
Table 33 North America: Venous Closure Products Market Size, By Country, 2014-2021 (USD Million)
Table 34 Europe: Venous Closure Products Market Size, By Country, 2014-2021 (USD Million)
Table 35 Surgical Products Market Size, By Region, 2014-2021 (USD Million)
Table 36 North America: Surgical Products Market Size, By Country, 2014-2021 (USD Million)
Table 37 Europe: Surgical Products Market Size, By Country, 2014-2021 (USD Million)
Table 38 Market Size, By Region, 2014-2021 (USD Million)
Table 39 Market Size, By Country 2014-2021 (USD Million)
Table 40 North America: Market Size, By Country and Treatment Mode, 2016 (USD Million)
Table 41 North America: Market Size, By Country, 2014-2021 (USD Million)
Table 42 North America: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 43 North America: Market Size, By Product, 2014-2021 (USD Million)
Table 44 U.S.: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 45 U.S.: Market Size, By Product, 2014-2021 (USD Million)
Table 46 Canada: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 47 Canada: Market Size, By Product, 2014-2021 (USD Million)
Table 48 Europe: Market Size, By Country and Treatment Mode, 2016 (USD Million)
Table 49 Europe: Market Size, By Country, 2014-2021 (USD Million)
Table 50 Europe: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 51 Europe: Market Size, By Product, 2014-2021 (USD Million)
Table 52 Germany: Market Size, By Treatment Mode, 2014-2021 (USD Million)
Table 53 Germany: Market Size, By Product, 2014-2021 (USD Million)
Table 54 France: Market Size, By Treatment Mode, 2014-2021 (USD Million)
Table 55 France: Market Size, By Product, 2014-2021 (USD Million)
Table 56 U.K.: Market Size, By Treatment Mode, 2014-2021 (USD Million)
Table 57 U.K.: Market Size, By Product, 2014-2021 (USD Million)
Table 58 Italy: Market Size, By Treatment Mode, 2014-2021 (USD Million)
Table 59 Italy: Market Size, By Product, 2014-2021 (USD Million)
Table 60 Spain: Market Size, By Treatment Mode, 2014-2021 (USD Million)
Table 61 Spain: Market Size, By Product, 2014-2021 (USD Million)
Table 62 Rest of Europe: Market Size, By Treatment Mode, 2014-2021 (USD Million)
Table 63 Rest of Europe: Market Size, By Product, 2014-2021 (USD Million)
Table 64 New Product Launches (2013-2016) (CNTD…)
Table 65 Acquisitions (2013-2016)
Table 66 Agreements (2013-2016)
Table 67 Other Developments (2013-2016)

List of Figures

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, & Country
Figure 3 North American Varicose Vein Treatment Market, By Country: Market Share (2016) and CAGR (2016 2021)
Figure 4 European Market, By Country: Market Share (2016) and CAGR (2016 2021)
Figure 5 Healthcare Expenditures as Percentage of GDP in Major European Countries
Figure 6 Key Markets: Changing Proportion of Geriatric Individuals (Aged 65 Years and Above) in Total Population (2020 vs. 2030)
Figure 7 Market Share, By Product (2016 2021) (USD Million)
Figure 8 North America: Market, By Mode of Treatment, 2016 (%)
Figure 9 North America: Market Share, By Country (2016 vs. 2021)
Figure 10 North America: Market Share, By Mode of Treatment, 2016
Figure 11 Europe: Market, By Mode of Treatment, 2016 (USD Million)
Figure 12 Europe: Market Share, By Country (2016 vs. 2021)
Figure 13 EU 5: Market Share, By Mode of Treatment, 2016
Figure 14 Leading Market Players Adopted Product Development and Commercialization as Key Growth Strategies During 2012 2015
Figure 15 Market Share, By Key Player (2015)
Figure 16 Product Development, the Most Widely Adopted Growth Strategy During 2013 2016
Figure 17 Geographic Benchmarking
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
5 of 5
- Angiodynamics, Inc. (U.S.)
- Biolitec Ag (Austria)
- Lumenis Ltd. (Israel)
- Medtronic, PLC (U.S.)
- Syneron Medical Ltd. (Israel)
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll